G proteins and hypertension: An alternative candidate gene approach

Kidney International

Volumn 53, Issue 6, 1998, Pages 1466-1470

  Siffert, Winfried ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Blood pressure; Essential hypertension; Immortalized cells; Intracellular signal transduction; Polygenetic disorder

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN;

AUTOSOMAL DOMINANT DISORDER; BLOOD PRESSURE MONITORING; CONFERENCE PAPER; ENVIRONMENTAL FACTOR; ESSENTIAL HYPERTENSION; GENE THERAPY; LIDDLE SYNDROME; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0031782464     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00934.x     Document Type: Conference Paper

References (40)

1. LIFTON RP: Genetic determinants of human hypertension. Proc Natl Acad Sci USA 92:8545-8551, 1995
2. LIFTON RP: Molecular genetics of human blood pressure variation. Science 272:676-680, 1996
3. SHIMKETS RA, WARNOCK DG, BOSITIS CM, NELSON-WILLIAMS C, HANSSON JH, SCHAMBELAN M, GILL JR JR, ULICK S, MILORA RV, FINDLING JW, CANESSA CM, ROSSIER BC, LIFTON RP: Liddle's syndrome: Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell 79:407-414, 1994
4. HANSSON JH, NELSON-WILLIAMS C, SUZUKI H, SCHILD L, SHIMKETS R, LU Y, CANESSA C, IWASAKI T, ROSSIER B, LIFTON RP: Hypertension caused by a truncated epithelial sodium channel y subunit: Genetic heterogeneity of Liddle syndrome. Nature Genet 11:76-82, 1995
5. SCHUSTER H, WIENKER TF, BÄHRING S, BILGINTURAN N, TOKA HR, NEITZEL H, JESCHKE E, TOKA O, GILBERT D, LOWE A, OTT J, HALLER H, LUFT FC: Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12. Nature Genet 13:98-100, 1996
6. SCHUSTER H, WIENKER TF, TOKA HR, BÄHRING S, JESCHKE E, TOKA O, BUSJAHN A, HEMPEL A, TAHLHAMMER C, OELKERS W, KUNZE J, BILGINTURAN N, HALLER H, LUFT FC: Autosomal dominant hypertension and brachydactyly in a Turkish kindred resembles essential hypertension. Hypertension 28:1085-1092, 1996
7. JEUNEMAITRE X, SOUBRIER F, KOTELEVTSEV YV, LIFTON RP, WILLIAMS CS, CHARRU A, HUNT SC, HOPKINS PN, WILLIAMS RR, LALOUEL J-M, CORVOL P: Molecular basis of human hypertension: Role of angiotensinogen. Cell 71:169-180, 1992
8. CUSI D, BARLASSINA C, AZZANI T, CASARI G, CITTERIO L, DEVOTO M, GLORIOSO N, LANZANI C, MANUNTA P, RIGHETTI M, RIVERA R, STELLA P, TROFFA C, ZAGATO L, BIANCHI G: Polymorphism of α-adducin and salt sensitivity in patients with essential hypertension. Lancet 349:1353-11357, 1997
9. BIANCHI G, TRIPODI G, CASARI G, SALARDI S, BARBER BR, GARCIA R, LEONI P, TORIELLI L, CUSI D, FERRANDI M, PINNA LA, BARALLE FE, FERRARI P: Two point mutations within the adducin genes are involved in blood pressure variation. Proc Natl Acad Sci USA 91:3999-4003, 1994
10. + exchange are mediated by the same transport protein in human red blood cells: An NMR investigation. Biochemistry 35:12433-12442, 1996
11. BUSCH S, BURCKHARDT B-C, SIFFERT W: Expression of the human sodium-proton exchanger NHE-1 in Xenopus laevis oocytes enhances sodium-proton exchange activity and establishes sodium-lithium countertransport. Pflügers Arch 429:859-869, 1995
12. LAURENZI M, TREVISAN M: Sodium-lithium countertransport and blood pressure: The Gubbio population study. Hypertension 13:408-415, 1989
13. KROLEWSKI AS, CANESSA M, WARRAM JH, LAFFEL LMB, CHRISTLIEB AR, KNOWLER WC, RAND LI: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 318:140-145, 1988
14. + exchange in hypertension and in diabetes mellitus-Facts and hypotheses. Basic Res Cardiol 91:179-190, 1996
15. ROSSKOPF D, DÜSING R, SIFFERT W: Membrane sodium-proton exchange and primary hypertension. Hypertension 21:607-617, 1993
16. SIFFERT W, DÜSING R: Sodium-proton exchange and primary hypertension-An update. Hypertension 26:649-655, 1995
17. + exchanger isoforms. Am J Physiol Cell Physiol 268:C283-C296, 1995
18. + exchanger isoform 1 (NHE1) is a novel member of the calmodulin-binding proteins. Identification and characterization of calmodulin-binding sites. J Biol Chem 269:13703-13709, 1994
19. + exchange in human lymphocytes and platelets in chronic and subacute metabolic acidosis. J Clin Invest 92:858-865, 1993
20. + exchanger activity and NHE-1 mRNA levels in human lymphocytes during metabolic acidosis. Am J Physiol Cell Physiol 266:C480-C488, 1994
21. + exchange increases after an oral glucose challenge. Circ Res 77:1024-1029, 1995
22. + antiport and cytosolic alkalinization in healthy human subjects. Clin Investig 72:817-821, 1994
23. + exchanger in man. Eur J Clin Invest 27:558-565, 1997
24. + antiport: Activation in primary hypertension and during chronic NaCl-loading. Eur J Clin Invest 24:529-539, 1994
25. ROSSKOPF D, FRÖMTER E, SIFFERT W: Hypertensive sodium-proton exchanger phenotype persists in immortalized lymphoblasts from essential hypertensive patients-A cell culture model for human hypertension. J Clin Invest 92:2553-2559, 1993
26. + antiporter phenotype, abundance, and phosphorylation of immortalized lymphoblasts from humans with hypertension. Hypertension 25:971-977, 1995
27. ROSSKOPF D, SCHRÖDER K-J, SIFFERT W: Role of sodium-hydrogen exchange in the proliferation of immortalised lymphoblasts from patients with essential hypertension and normotensive subjects. Cardiovasc Res 29:254-259, 1995
28. + exchanger isoform-1 of human lymphoblasts in hypertension. Metabolism 46:297-302, 1997
29. SIFFERT W, ROSSKOPF D, MORITZ A, WIELAND T, KALDENBERG-STASCH S, KETTLER N, HARTUNG K, BECKMANN S, JAKOBS KH: Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension. J Clin Invest 96:759-766, 1995
30. MAZER BD, SAWAMI H, TORDAI A, GELFAND LW: Platelet-activating factor-mediated transmembrane signaling in human B lymphocytes is regulated through a pertussis- and cholera toxin-sensitive pathway. J Clin Invest 90:759-765, 1992
31. o by mastoparan, related amphiphilic peptides, and hydrophobic amines. J Biol Chem 265:14176-14186, 1990
32. GRUSKA S, IHRKE R, STOLPER S, KRAATZ G, SIFFERT W: Prevalence of increased intracellular signal transduction in immortalized lymphoblasts from patients with essential hypertension and normotensive subjects. J Hypertens 15:29-33, 1997
33. β2 are not mutated. Circ Res 79:974-983, 1996
34. MCLELLAN AR, MILLIGAN G, HOUSLAY MD, CONNELL JMC: G-proteins in essential hypertension: A study on human platelet plasma membranes. J Hypertens 11:543-549, 1993
35. o in reconstituted phospholipid vesicles. J Biol Chem 264:3909-3915, 1989
36. PHILLIPS WJ, WONG SC, CERIONE RA: Rhodopsin/transducin interactions. II. Influence of the transducin-βγ subunit complex on the coupling of the transducin-α subunit to rhodopsin. J Biol Chem 267:17040-17046, 1992
37. 2+ response in transformed lymphoblasts. Hypertension 29: 158-164, 1997
38. HALLER H, LINDSCHAU C, QUASS P, DISTLER A: Protein phosphorylation and intracellular free calcium in platelets of patients with essential hypertension. Am J Hypertens 5:117-124, 1992
39. LECHI A, LECHI C, BONADONNA G, SINIGAGLIA D, CORRADINI P, POLIGNANO R, AROSIO E, COVI G, DE TOGNI P: Increased basal and thrombin-induced free calcium in platelets of essential hypertensive patients. Hypertension 9:230-235, 1987
40. DOMINICZAK AF, MORTON JJ, MURRAY G, SEMPLE PF: Platelet cytosolic free calcium in essential hypertension: Responses to vasopressin. Clin Sci 77:183-188, 1989